Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 919 clinical trials
Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort

Background Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory disease of the lungs, which is most commonly caused by smoking. It is characterized as not fully reversible

obstruction
obstructive lung disease
spirometry
pulmonary function test
bronchodilator
  • 5 views
  • 04 Feb, 2021
  • 1 location
Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease (COPD)

According to the WISDOM study, withdraw of inhaled steroids has no effect on the acute exacerbation of chronic obstructive pulmonary disease (COPD), but the lung function of patients with COPD

corticosteroids
acute exacerbation of chronic obstructive pulmonary disease
pneumonia
inhaled steroids
pulmonary function test
  • 0 views
  • 24 Jan, 2021
  • 1 location
Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)

The purpose of the LINQ for COPD study is to characterize Reveal LINQ derived data from patients with COPD by assessing the relationship between changes in LINQ derived data with COPD

respiratory symptom
bronchodilator
copd exacerbation
prednisone
  • 0 views
  • 18 Feb, 2021
  • 5 locations
Mechanisms of COPD Exacerbation Recurrence

Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung disease. Patients with COPD are at increased risk of readmission to hospitals within the following 30 days. Hospital

pulmonary function test
pulmonary disease
copd exacerbation
spirometry
  • 1 views
  • 22 Jan, 2021
  • 1 location
Activity Balance and COPD (ABCOPD)

(activity measured in day to day life) in people with COPD and other chronic lung diseases.

  • 2 views
  • 23 Jan, 2021
Characteristics of People With Advanced Chronic Obstructive Pulmonary Disease (COPD) - A Multicenter Study

Pulmonary rehabilitation (PR) is a cornerstone of care for people with COPD. There is robust evidence that PR improves exercise capacity, enhances health-related quality of life (QoL) and

pulmonary rehabilitation
forced expiratory volume
  • 0 views
  • 10 May, 2021
  • 4 locations
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD Emphysema and Asthma-COPD Overlap

years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled

bronchitis
corticosteroids
COPD
bronchiectasis
pulmonary disease
  • 54 views
  • 19 Feb, 2021
  • 1 location
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease that affects only a fraction of those who smoke tobacco. The origin of this variability in susceptibility to develop COPD

  • 0 views
  • 12 May, 2021
  • 3 locations
Medication Adherence Research in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death, affects over 24 million people in the US and is the leading cause of disability with projected healthcare costs

forced expiratory volume
  • 78 views
  • 26 Jan, 2021
  • 2 locations
Cardiovascular Risk and Chronic Obstructive Pulmonary Disease

indicative of evolving cardiovascular risk (CVR) in COPD patients, using multivariate analysis.

respiratory failure
  • 0 views
  • 13 Feb, 2021
  • 1 location